Notícia

Time 24 News (EUA)

Pulmonary hypertension medication may become an option against cancer

Publicado em 06 abril 2021

In experiments with mice and in tests with tumor cell lines, the drug has the potential to combat metastasis. Researchers from USP plan clinical trial with patients undergoing chemotherapy.

A drug used to treat pulmonary hypertension significantly reduced the ability of tumor cells to migrate and invade other tissues in tests performed on pancreatic, ovarian, breast and leukemia tumor lines. In addition, in mice with an aggressive form of breast cancer, the drug reduced the incidence of metastasis in the liver and lungs by 47%, as well as increased survival compared to untreated animals. The study was published in the journal Scientific Reports .

“The drug ambrisentan is an inhibitor of the endothelin A receptor, which plays a role in constricting blood vessels. So it is used to treat pulmonary hypertension [normalmente causada por doenças autoimunes como lúpus e esclerose sistêmica]. In the laboratory, we saw that the drug has an effect on tumor cells, preventing the migration of these cells to other tissues, in addition to other effects that we are still investigating ”, explains Otávio Cabral Marques, a researcher at the Institute of Biomedical Sciences at the University of São Paulo ( ICB-USP) and coordinator of the study, financed by FAPESP.

Marques conducted the work during his post-doctorate at the University of Freiburg, in Germany, in collaboration with researchers from that country and the United Arab Emirates. Currently, he coordinates a project supported by FAPESP in the Young Researcher modality.

The type A endothelin receptor is known to be expressed in the endothelium, the layer that lines the inner wall of blood vessels, and in cells of the immune system. Other studies have also shown that it is involved in the growth and metastasis of several tumors.

“It seems that the drug’s effect is not only on the migration of tumor cells, but also on neoangiogenesis, that is, on the formation of new blood vessels necessary to feed the tumor. We are conducting experiments to prove this. If confirmed, the drug would have a systemic effect, not only inhibiting the migration of the tumor to other tissues, but also blocking the generation of new vessels that make it grow ”, says the researcher.

The benefit of the drug for the treatment of cancer has not yet been proven. Use without medical advice can pose a health risk, especially for pregnant women.

Experiments

Using a technique to measure cell migration, the researchers noted that the drug significantly reduced this phenomenon in both tumor cells that received a stimulus and spontaneous migration. Strains of ovarian, leukemia, pancreas and breast tumors were tested.

Then, mice in the early stage of an aggressive breast cancer strain (4Q1) were treated for two weeks before the tumor was implanted and two weeks later. In this experiment, the reduction in metastasis was 43%, increasing the animals’ survival.

“As the metastasis of 4T1 cells occurs very quickly in mice, we started the treatment earlier, so that we could get closer to what would happen to humans”, he explains.

Now, with other researchers from the ICB-USP, Marques is preparing to carry out clinical tests. The idea is to test the drug in a group of patients who are already undergoing chemotherapy and see if they recover better than another group (control) that undergoes only standard treatment.

Although the drug has the advantage of being able to be administered orally, the researcher believes in the possibility of making a direct application in the tumor, in order to increase its effect. It has not yet been defined in what type of cancer clinical tests will be done.

O artigo Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis pode ser lido em: www.nature.com/articles/s41598-020-72960-1

By André Julião | FAPESP Agency

Essa notícia também repercutiu nos veículos:
Folha de Pernambuco online UOL Portal R7 Estado de Minas online Estado de Minas Quimiweb Diário do Pará online Meio Norte online (Piauí) Galileu online A Crítica (AM) online Belém online Viralizado A Crítica (MS) online O Estado do Maranhão online Portal da Enfermagem Jornal Alerta CliqueABC Coluna Supinando Saense RM Consult Coluna Supinando Diga Bahia FOCEP Brasil Blog Jornal da Mulher Blog De Tudo Um Pouco Blog da Carol Araujo Blog Petrolândia Conectada Araraquara24horas Blog da Simone Duarte Jornal Fatos & Notícias Blog de Notícias Vida FM Casa de Notícias Saúde em Tela Panorama Farmacêutico Newsbeezer (Portugal) Pelo Mundo DF Confap - Conselho Nacional das Fundações Estaduais de Amparo à Pesquisa Portal do Governo do Estado de São Paulo Pfarma Antenados Rede Interativa Zatum Novo Cantu Notícias Diário em Foco Roberto Crispim Mix Vale BSB Notícias Agência de Notícias – Defesa Rádio Nova Onda FM 87,9 Notícias ao Minuto (Brasil) Rádio Cultura FM 101,7 Roberto Crispim Região Noroeste Nova Mais Radar C InfoNavWeb Jornal SP Norte Rádio Cidade Nova FM 104,9 Biblioteca FMUSP Tem de Tudo News Rádio Liberdade FM 87,9 Guia Viver Bem Beto Ribeiro Repórter Plantão News (MT) Mato Grosso Digital São Bento em Foco Portal Agora Notícias Folha de Sabará online Acontece no RS Guarantã News Farmacêutico Márcio Antoniassi Blog Lajes News - RN Folha de Itapetininga Panorama Farmacêutico Sete Lagoas.com.br Click Sete Conecta Oeste Rota do Sertão Coluna Supinando Portal Niterói Zona Sul Notícias Blog 3 Poderes O Melhor da Cidade Portal Terra Santa Notícias Rádio Uau Portal Niterói Grava News - Jornal de Alfenas Minha Pará de Minas Cidade Notícia Lucas em foco Garanhuns Notícias Acre ao Vivo Zona Sul Notícias Penha News Portal G86 Portal Manhumirim Radar MT Patriota SP Conexão Na Cidade Viva Marília Portal Afunilados Verguia Fatos Locais Diário D4 Notícias Extra News MS Rio Brilhante News Grupo News Paraná Giro 7 Giro Notícias Goiás Oeste Ao Vivo A Voz dos Municípios (Laranjeiras, Sergipe) online BF News Capital Bahia Jornal Piauí Noticias Oeste 360 Alagoas Agora online Poder e Notícia LauroCITY MaisAM Maranhão em Pauta Metropolitana MS Brasil de Olho Bom Dia Cidade Notícias Cabreúva Online Rádio Leme FM Relata Bahia Toni Rodrigues Portal Chapada Grande Rádio Atalaia FM 87,9 REEN - Rede de Entretenimento, Esportes e Notícias Jornal da Ciência (Angola) Blog Diário Tancredense Portal do Parente Palavra Franca Canal Farma - Tech4Health Blog Colado na Notícia Blog Jornal Primeira Hora Rádio Mapele FM Shape Forte Toda Hora Web Jornal A Voz do Povo online (Uberlândia, MG) Oeste 360 Rádio Leme FM